Comment on RTP drugmaker plans 'headcount reductions' after failing late-stage trial

RTP drugmaker plans 'headcount reductions' after failing late-stage trial

G1 Therapeutics has failed to hit its target in a pivotal, late-stage trial and is signaling more layoffs ahead.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News